Ovarian

The trials listed below are accepting new patients.  Interested patients can Email the coordinator by clicking on envelope icon. Please include a phone number and best times to call.

Treatment Phase
Short Name
Protocol Title 
ClinicalTrial.Gov link
Penn Research Coordinator
 Am I Eligible?

Newly diagnosed stage 2-4

NRG-GY019

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian or Primary Peritoneal Cancer

 NCT04095364

 

Christine Yang 

Eligibility Criteria

Recurrent

CAPRI

Combination ATR and PARP Inhibitor with AZD6738 and Olaparib in Recurrent Ovarian Cancer

NCT03462342

Cristian Tolento

Eligibility Criteria
Recurrent

TC 210

 Phase 1/2 Trial of TC-210 T Cells in Patients With Advanced Mesothelin-Expressing Cancer

NCT03907852

Katie Elkins

Eligibility Criteria
Recurrent  GOG3059 A Phase 3, Randomized, Double-Blind, Adaptive,
Placebo/Paclitaxel-Controlled Study of AVB-S6-500 in
Combination with Paclitaxel in Patients with Platinum-
Resistant Recurrent Ovarian Cancer (AXLerate-OC)
NCT04729608 Isabel Forbes Eligibility Criteria